Population pharmacokinetic parameters for bayesian monitoring of amikacin therapy in intensive care unit patients
暂无分享,去创建一个
J. Debord | G. Lachâtre | R. Gay | J. Voultoury | J. Favereau | C. Gay
[1] J. Rello,et al. Gentamicin volume of distribution in critically ill septic patients , 2005, Intensive Care Medicine.
[2] R. Jelliffe,et al. Individualising Gentamicin Dosage Regimens , 1991, Clinical pharmacokinetics.
[3] K. Rodvold,et al. An Updated Comparison of Drug Dosing Methods , 1991, Clinical pharmacokinetics.
[4] K. Rodvold,et al. An Updated Comparison of Drug Dosing Methods , 1991, Clinical pharmacokinetics.
[5] K. Rodvold,et al. Bayesian Forecasting of Serum Gentamicin Concentrations in Intensive Care Patients , 1990, Clinical pharmacokinetics.
[6] R. Fischer,et al. Pharmacokinetic monitoring of nephrotoxic antibiotics in surgical intensive care patients. , 1988, The Journal of trauma.